Suppr超能文献

[早期乳酸清除率对接受体外膜肺氧合治疗的严重急性呼吸衰竭患者的预后意义]

[Prognostic significance of early lactate clearance rate for severe acute respiratory failure patients on extracorporeal membrane oxygenation].

作者信息

Zang Zhidong, Xu Hongyang, Dong Liang, Gao Fei, Yan Jie

机构信息

Department of Critical Care Medicine, Wuxi People's Hospital Affiliated to Nanjing Medicial University, Wuxi 214023, China. Email:

Department of Critical Care Medicine, Wuxi People's Hospital Affiliated to Nanjing Medicial University, Wuxi 214023, China.

出版信息

Zhonghua Jie He He Hu Xi Za Zhi. 2014 Mar;37(3):197-201.

Abstract

OBJECTIVE

To investigate the prognostic significance of early lactate clearance rate for severe acute respiratory failure patients on extracorporeal membrane oxygenation (ECMO).

METHODS

Forty-three patients with severe acute respiratory failure supported by venous-venous (v-v) ECMO were enrolled from January 2007 to January 2013. Arterial blood lactate at pre-ECMO support(0 h) and at post-ECMO 6 hours (6 h) were measured and then 6 h lactate clearance rate was calculated. The acute physiology and chronic health evaluation II (APACHEII) score was evaluated on the first day of ECMO support. Survival at 90 d after admission was the study endpoint. Patients were divided into the survival group (n = 24) and the death group (n = 19) . The 0 h blood lactate, 6 h lactate clearance rate and APACHE II score were compared between groups. The value of 0 h blood lactate, 6 h lactate clearance rate and APACHE II score for predicting death was evaluated by receiver operating characteristic (ROC) curves. The surviving curve was drawn using the Kaplan-Meier method, and the survival of the patients was analyzed by the Log-rank test. Factors influencing the prognosis were analyzed by the multiple logistic regression analysis.

RESULTS

(1) The 0 h blood lactate and APACHE II score were lower in survivors than in nonsurvivors [(3.8 ± 2.1) mmol/L vs. (5.9 ± 2.3) mmol/L, (18 ± 7) vs. (25 ± 7) , t = 7.924, 8.446, respectively, both P < 0.05], while the 6 h lactate clearance rate was higher in survivors than in nonsurvivors [(35.7 ± 20.4) % vs. (10.7 ± 18.2) %, t = 8.607, P < 0.05]. (2) The areas under the ROC curve of 0 h blood lactate, 6 h lactate clearance rate and APACHE II score for predicting death were 0.699 ± 0.083 (95%CI:0.567∼0.892, P < 0.05) , 0.871 ± 0.119 (95%CI:0.724∼0.980, P < 0.05) and 0.836 ± 0.063 (95%CI: 0.713∼0.958, P < 0.05) . The best cutoff point was 17.5% for 6 h lactate clearance with a sensitivity of 87.5% and specificity of 84.2%. (3) Kaplan-Meier survival analysis showed that 90 d survival rate of the high lactate clearance rate group and the low lactate clearance rate group were 78.3% and 30%, with significant difference between the two groups (χ² = 10.103, P < 0.05). (4) Multivariate logistic regression analysis showed that 0 h blood lactate (OR = 1.318, 95%CI:1.159∼6.882, P < 0.05) , 6 h lactate clearance rate (OR = 6.921, 95%CI:4.469∼15.036, P < 0.05) and APACHEII score (OR = 4.417, 95%CI:3.058∼10.356, P < 0.05) were independent risk factors associated with mortality of patients on ECMO.

CONCLUSION

Early lactate clearance rate could be used as an important variable for evaluating the prognosis of severe acute respiratory failure patients on ECMO.

摘要

目的

探讨早期乳酸清除率对接受体外膜肺氧合(ECMO)治疗的严重急性呼吸衰竭患者预后的意义。

方法

选取2007年1月至2013年1月期间43例接受静脉-静脉(v-v)ECMO支持的严重急性呼吸衰竭患者。测定ECMO支持前(0小时)及ECMO支持后6小时(6小时)的动脉血乳酸水平,计算6小时乳酸清除率。在ECMO支持的第一天评估急性生理与慢性健康状况评分系统II(APACHEII)评分。以入院后90天生存率作为研究终点。将患者分为生存组(n = 24)和死亡组(n = 19)。比较两组间0小时血乳酸、6小时乳酸清除率及APACHE II评分。采用受试者工作特征(ROC)曲线评估0小时血乳酸、6小时乳酸清除率及APACHE II评分预测死亡的价值。采用Kaplan-Meier法绘制生存曲线,并用Log-rank检验分析患者的生存情况。通过多因素logistic回归分析影响预后的因素。

结果

(1)生存者的0小时血乳酸及APACHE II评分低于非生存者[(3.8±2.1)mmol/L对(5.9±2.3)mmol/L,(18±7)对(25±7),t分别为7.924、8.446,均P<0.05],而生存者的6小时乳酸清除率高于非生存者[(35.7±20.4)%对(10.7±18.2)%,t = 8.607,P<0.05]。(2)0小时血乳酸、6小时乳酸清除率及APACHE II评分预测死亡的ROC曲线下面积分别为0.699±0.083(95%CI:0.567~0.892,P<0.05)、0.871±0.119(95%CI:0.724~0.980,P<0.05)和0.836±0.063(95%CI:0.713~0.958,P<0.05)。6小时乳酸清除率的最佳截断点为17.5%,敏感性为87.5%,特异性为84.2%。(3)Kaplan-Meier生存分析显示,高乳酸清除率组和低乳酸清除率组的90天生存率分别为78.3%和30%,两组间差异有统计学意义(χ² = 10.103,P<0.05)。(4)多因素logistic回归分析显示,0小时血乳酸(OR = 1.318,95%CI:1.159~6.882,P<0.05)、6小时乳酸清除率(OR = 6.921,95%CI:4.469~15.036,P<0.05)及APACHEII评分(OR = 4.417,95%CI:3.058~10.356,P<0.05)是与接受ECMO治疗患者死亡率相关的独立危险因素。

结论

早期乳酸清除率可作为评估接受ECMO治疗的严重急性呼吸衰竭患者预后的重要指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验